natgillin/translations-raw huggingface dataset:
Do not use this medicine after the expiry date which is stated on the carton and the blister after EXP. 
Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na kutiji i blisteru iza oznake „Rok valjanosti“ ili „EXP“.
Dose in patients with impaired kidney function 
Doziranje kod bolesnika s oštećenom funkcijom bubrega
Memantine did not inhibit CYP 1A2, 2A6, 2C9, 2D6, 2E1, 3A, flavin-containing monooxygenase, epoxide hydrolase or sulphation in vitro. 
Memantin nije in vitro inhibirao CYP 1A2, 2A6, 2C9, 2D6, 2E1, 3A, monooksigenazu koja sadržava flavin, epoksid hidrolazu niti sulfaciju.
Memantine LEK belongs to a group of medicines known as anti-dementia medicines. 
Memantine LEK se ubraja u skupinu lijekova poznatih kao lijekovi protiv demencije.
In the most extreme case of overdose, the patient survived the oral intake of a total of 2,000 mg memantine with effects on the central nervous system (coma for 10 days, and later diplopia and agitation). 
U najekstremnijem slučaju predoziranja, bolesnik je preživio peroralno uzimanje ukupne količine od 2000 mg memantina s učincima na središnji živčani sustav (koma tijekom 10 dana, a nakon toga diplopija i agitacija).
What is Memantine LEK used for Memantine LEK is used for the treatment of adult patients with moderate to severe Alzheimer's disease. 
Za što se Memantine LEK koristi Memantine LEK se koristi za liječenje odraslih bolesnika s umjerenom do teškom Alzheimerovom bolešću.
Memantine LEK should be administered once a day and should be taken at the same time every day. 
Memantine LEK treba primjenjivati jedanput na dan i potrebno ga je uzimati svaki dan u isto vrijeme.
Elevated liver function test Hepatitis 
Često povišeni rezultat testa jetrene funkcije
Also, Memantine LEK may change your reactivity, making driving or operating machinery inappropriate. 
Memantine LEK također može promijeniti Vašu sposobnost reagiranja, što čini upravljanje vozilima i rad na strojevima neprikladnima.
Verovškova 57, 1526 Ljubljana Slovenia 
Lek Pharmaceuticals d.d. Verovškova 57, 1526 Ljubljana Slovenija
Memantine LEK is not recommended for use in children and adolescents below 18 years due to a lack of data on safety and efficacy. 
Primjena lijeka Memantine LEK kod djece i adolescenata mlađih od 18 godina se ne preporučuje zbog nedostatka podataka o sigurnosti i djelotvornosti.
In these situations the treatment should be carefully supervised, and the clinical benefit of Memantine LEK reassessed by your doctor on a regular basis. 
U tim slučajevima liječenje mora biti pažljivo nadzirano, a liječnik treba redovito ponovno procjenjivati kliničku korist od uzimanja lijeka Memantine LEK.
Daily doses of 20 mg lead to steady-state plasma concentrations of memantine ranging from 70 to 150 ng/mL (0.5 - 1 μmol) with large interindividual variations. 
Dnevne doze od 20 mg dovode do plazmatskih koncentracija memantina u stanju dinamičke ravnoteže u rasponu od 70 do 150 ng/mL (0,5 - 1 µmol) s velikim interindividualnim razlikama.
At a dose of memantine of 20 mg per day the CSF levels match the ki-value (ki= inhibition constant) of memantine, which is 0.5 μmol in human frontal cortex. 
Pri dozi od 20 mg memantina dnevno, razine u CSL-u odgovaraju ki-vrijednosti (ki = konstanta inhibicije) memantina, koja u frontalnom korteksu kod ljudi iznosi 0,5 µmol.
These active substances act at the same receptor system as memantine, and therefore adverse reactions (mainly central nervous system (CNS)-related) may be more frequent or more pronounced (see also section 4.5). 
Ovi spojevi djeluju na isti sustav receptora kao i memantin, te bi nuspojave (uglavnom povezane sa središnjim živčanim sustavom (SŽS)) mogle biti učestalije ili izraženije (vidjeti također dio 4.5).
Furthermore, Memantine LEK has minor or moderate influence on the ability to drive and use machines such that outpatients should be warned to take special care. 
Nadalje, Memantine LEK ima blagi ili umjereni utjecaj na sposobnost upravljanja vozilima i rada na strojevima, pa ambulantne bolesnike treba upozoriti da na to obrate posebnu pozornost.
• if you are allergic to memantine hydrochloride or any of the other ingredients of this medicine (listed in section 6). 
Nemojte uzimati Memantine LEK • ako ste alergični na memantinklorid ili bilo koji drugi sastojak ovog lijeka (naveden u dijelu 6).
What Memantine LEK is and what it is used for What you need to know before you take Memantine LEK How to take Memantine LEK Possible side effects 
Što je Memantine LEK i za što se koristi Što morate znati prije nego počnete uzimati Memantine LEK Kako uzimati Memantine LEK
The recommended dose of Memantine LEK for adults and elderly patients is 20 mg once a day. 
Preporučena doza lijeka Memantin LEK za odrasle i starije bolesnike je 20 mg jedanput na dan.
Adults 
Odrasli:
Main human metabolites are N-3,5-dimethyl-gludantan, the isomeric mixture of 4-and 6-hydroxy-memantine, and 1-nitroso-3,5-dimethyl-adamantane. 
Glavni metaboliti kod ljudi su N-3,5-dimetil-gludantan, izomerna mješavina 4- i 6-hidroksi-memantina i 1-nitrozo-3,5dimetil-adamantan.
(≥1/10), common (≥1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥1/10,000 to <1/1,000), very rare (< 1/10,000), not known (cannot be estimated from the available data). 
1/1000), vrlo rijetko (< 1/10 000), nepoznato (ne može se procijeniti iz dostupnih podataka).
In single-dose pharmacokinetic (PK) studies in young healthy subjects, no relevant active substance - active substance interaction of memantine with glyburide/metformin or donepezil was observed. 
U farmakokinetičkim ispitivanjima (PK) u kojima su primijenjene pojedinačne doze kod mladih zdravih ispitanika nije uočena značajna interakcija djelatna tvar-djelatna tvar između memantina i gliburida/metformina ili donepezila.
Memantine LEK acts on these NMDA-receptors improving the transmission of nerve signals and the memory. 
Memantine LEK djeluje na navedene NMDA receptore poboljšavajući prijenos živčanih signala i pamćenje.
What Memantine LEK contains 
Što Memantine LEK sadrži
In patients with moderate renal impairment (creatinine clearance 30 - 49 mL/min) daily dose should be 10 mg per day. 
Kod bolesnika s umjerenim oštećenjem bubrega (klirens kreatinina 30-49 mL/min) dnevna doza bi trebala biti 10 mg na dan.
Concomitant administration of memantine with the antispasmodic medicinal products, dantrolene or baclofen, can modify their effects and a dose adjustment may be necessary. 
Istodobna primjena memantina sa spazmoliticima, dantrolenom ili baklofenom, može promijeniti njihov učinak te će možda biti potrebna prilagodba doze.
This is increased to one tablet of 10 mg once a day (1x 10 mg) in the second week and to 1 and a half tablet of 10 mg once a day in the third week. 
Ova doza se povećava na jednu tabletu od 10 mg jedanput na dan (1 x 10 mg) u drugom tjednu te na jednu i pol tabletu od 10 mg jedanput na dan u trećem tjednu.
The usual starting dose is half a tablet of 10 mg once a day (1x 5 mg) for the first week. 
Uobičajena početna doza iznosi pola tablete od 10 mg jedanput na dan (1 x 5 mg) tijekom prvog tjedna.
In a study using orally administered 14C-memantine, a mean of 84% of the dose was recovered within 20 
U ispitivanju u kojem je korišten oralno primijenjen 14C-memantin, uklonjeno je prosječno 84% doze unutar 20 dana, više od 99% izlučeno je putem bubrega.
In volunteers with normal kidney function, total clearance (Cltot) amounts to 170 mL/min/1.73 m² and part of total renal clearance is achieved by tubular secretion. 
Kod dobrovoljaca s normalnom funkcijom bubrega ukupni klirens (Cltot) iznosi do 170 ml/min/1,73 m², a dio se ukupnog bubrežnog klirensa postiže tubularnom sekrecijom.
28 film-coated tablets 30 film-coated tablets 42 film-coated tablets 56 film-coated tablets 98 film-coated tablets 100 film-coated tablets 
28 filmom obloženih tableta 30 filmom obloženih tableta 42 filmom obložene tablete 56 filmom obloženih tableta 98 filmom obloženih tableta 100 filmom obloženih tableta
28 film-coated tablets 30 film-coated tablets 42 film-coated tablets 50 film-coated tablets 56 film-coated tablets 60 film-coated tablets 98 film-coated tablets 100 film-coated tablets 112 film-coated tablets 
28 filmom obloženih tableta 30 filmom obloženih tableta 42 filmom obložene tablete 50 filmom obloženih tableta 56 filmom obloženih tableta 60 filmom obloženih tableta 98 filmom obloženih tableta 100 filmom obloženih tableta 112 filmom obloženih tableta
In patients with mildly impaired renal function (creatinine clearance 50 - 80 mL/min) no dose adjustment is required. 
Kod bolesnika s blagim oštećenjem funkcije bubrega (klirens kreatinina 50-80 mL/min) nije potrebna prilagodba doze.
The study showed beneficial effects of memantine treatment in comparison to placebo at 6 months (observed cases analysis for the clinician's interview based impression of change (CIBIC-plus): p=0.025; Alzheimer's disease cooperative study - activities of daily living (ADCS-ADLsev): p=0.003; severe impairment battery (SIB): p=0.002). 
U 6. mjesecu ispitivanja pokazani su povoljni učinci liječenja memantinom u usporedbi s placebom (analiza opaženih slučajeva za promjene bazirane na dojmu kliničara nakon intervjua (CIBIC-plus): p=0,025; kooperativno ispitivanje Alzheimerove bolesti - aktivnosti svakodnevnog života (ADCS-ADLsev): p=0,003; skup znakova teške onesposobljenosti (SIB): p=0,002).
Memantine LEK should be administered orally once a day. 
Memantine LEK treba primjenjivati kroz usta jedanput na dan.
When patients were identified with concurrent worsening in all three domains, results showed a statistically significant effect of memantine in preventing worsening, as twice as many placebo-treated patients as memantine-treated patients showed worsening in all three domains (21% vs. 11%,p<0.0001). 
Kada je ustanovljeno istodobno pogoršanje stanja bolesnika u sva tri područja, rezultati su pokazali statistički značajan učinak memantina u sprječavanju pogoršanja, u skupini bolesnika liječenih placebom bilo je dvostruko više pogoršanja u sva tri područja nego u skupini bolesnika liječenih memantinom (21% naspram 11%, p<0,0001).
one and a half 10 mg tablets week 4 and beyond two 10 mg tablets or one 20 mg tablet once a day 
4. tjedan i nadalje dvije tablete od 10 mg ili jedna tableta od 20 mg jedanput na dan
SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IFAPPROPRIATE 
POSEBNE MJERE ZA ZBRINJAVANJE NEISKORIŠTENOG LIJEKA ILI
What Memantine LEK looks like and contents of the pack Memantine LEK 10 mg film-coated tablets are presented as yellow, oval film-coated tablet scored in one side. 
Kako Memantine LEK izgleda i sadržaj pakiranja Memantine LEK 10 mg filmom obložene tablete su žute boje, ovalnog oblika, urezane na jednoj strani.
Common (may affect up to 1 in 10 people): 
Česte (mogu se javiti kod 1 na 10 osoba):
The recommended maintenance dose is 20 mg per day. 
Preporučena doza održavanja je 20 mg dnevno.
Tablet core: croscarmellose sodium, colloidal anhydrous silica, microcrystalline cellulose, magnesium stearate 
Jezgra tablete: umrežena karmelozanatrij, koloidni bezvodni silicijev dioksid, mikrokristalična celuloza, magnezijev stearat.
Somnolence Confusion Hallucinations1 
Manje često konfuzija Manje često halucinacije1
Sandoz d.d Representative office Teл. 
Sandoz d.d. representative office Latvia.
Uncommon (may affect up to 1 in 100 people): 
Manje česte (mogu se javiti kod 1 na 100 osoba):
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER PACKING 
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA ZA BLISTER
Memantine LEK belongs to a group of medicines called NMDA-receptor antagonists. 
Memantine LEK spada u skupinu lijekova poznatih kao antagonisti NMDA
Memantine LEK 20 mg film-coated tablets are presented as pale red, oval film-coated tablet scored in one side. 
Memantine LEK 20 mg filmom obložene tablete su blijedo crvene boje, ovalnog oblika, urezane na jednoj strani.
INFORMATION IN BRAILLE Memantine LEK 20 mg 
16. PODACI NA BRAILLEOVOM PISMU Memantine LEK 20 mg
INFORMATION IN BRAILLE Memantine LEK 10 mg 
16. PODACI NA BRAILLEOVOM PISMU Memantine LEK 10 mg
Animal studies indicate a potential for reducing intrauterine growth at exposure levels, which are identical or slightly higher than at human exposure (see section 5.3). 
Nema podataka ili su podaci o primjeni memantina u trudnica ograničeni.Ispitivanja na životinjama upućuju na postojanje mogućnosti smanjenja intrauterinog rasta pri izloženosti dozama istim ili nešto višim nego što su kod ljudi (vidjeti dio 5.3).
In most clinical trials, patients with recent myocardial infarction, uncompensated congestive heart failure (NYHA III-IV), or uncontrolled hypertension were excluded. 
nekompenzirano kongestivno zatajenje srca (NYHA III-IV) ili nekontroliranu hipertenziju.
Memantine LEK contains the active substance memantine hydrochloride. 
Memantin LEK sadrži djelatnu tvar memantinklorid.
Memantine LEK is for oral use. 
Memantin LEK je za peroralnu primjenu.
Constipation Vomiting Pancreatitis2 
Nepoznato pankreatitis2
Marketing Authorisation Holder Pharmathen S.A., 6, Dervenakion str., 15351 Pallini, Attiki, Greece 
Nositelj odobrenja za stavljanje lijeka u promet Pharmathen S.A., 6, Dervenakion str., 15351 Pallini, Attiki, Grčka
From the fourth week on, the usual dose is 2 tablets once a day (1 x 20 mg). 
uobičajena doza je 2 tablete jedanput na dan (1 x 20 mg).
In this case, monitoring of your kidney function should be performed by your doctor at specified intervals. 
U tom slučaju liječnik bi trebao u određenim razmacima nadzirati funkciju bubrega.
On the basis of the clinical studies, the recommended dose for patients over the age of 65 years is 20 mg per day as described above. 
Temeljem kliničkih ispitivanja, preporučena doza za bolesnike starije od 65 godina iznosi 20 mg dnevno
Women taking Memantine LEK should not breast-feed. 
Žene koje uzimaju Memantin LEK ne smiju dojiti.
Film-coating: polyvinyl alcohol, titanium dioxide (E-171), talc, macrogol 3350, iron oxide yellow (E172) and iron oxide red (E-172) 
Film ovojnica: poli(vinilni alkohol), titanijev dioksid (E171), talk, makrogol 3350, žuti željezov oksid (E172) i crveni željezov oksid (E172).
Very Rare (may affect up to 1 in 10,000 people): • Seizures 
Vrlo rijetke (mogu se javiti kod 1 na 10 000 osoba):
How to take Memantine LEK 
Kako uzimati Memantine LEK
Common Common Uncommon Very rare 
Manje često abnormalni hod Vrlo rijetko napadaji
amantadine, ketamine, dextromethorphan dantrolene, baclofen cimetidine, ranitidine, procainamide, quinidine, quinine, nicotine hydrochlorothiazide (or any combination with hydrochlorothiazide) anticholinergics (substances generally used to treat movement disorders or intestinal cramps) anticonvulsants (substances used to prevent and relieve seizures) barbiturates (substances generally used to induce sleep) dopaminergic agonists (substances such as L-dopa, bromocriptine) neuroleptics (substances used in the treatment of mental disorders) oral anticoagulants 
amantadina, ketamina, dekstrometorfana dantrolena, baklofena cimetidina, ranitidina, prokainamida, kinidina, kinina, nikotina hidroklorotiazida (ili bilo koje kombinacije s hidroklorotiazidom)
Talk to your doctor or pharmacist before taking Memantine LEK 
Upozorenja i mjere opreza Obratite se svom liječniku ili ljekarniku prije nego uzmete Memantin LEK.
There is increasing evidence that malfunctioning of glutamatergic neurotransmission, in particular at NMDA-receptors, contributes to both expression of symptoms and disease progression in neurodegenerative dementia. 
NMDA-receptorima, doprinosi izraženosti simptoma i progresiji bolesti kod neurodegenerativne demencije.
NAME OF THE MARKETING AUTHORISATION HOLDER Pharmathen S.A. 
NAZIV NOSITELJA ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET Pharmathen S.A.
Administration of Memantine LEK is not recommended in patients with severe hepatic impairment. 
Ne preporučuje se primjena lijeka Memantine LEK kod bolesnika s teškim oštećenjem jetre.
Yellow, oval film-coated tablet scored in one side. 
Žuta filmom obložena tableta ovalnog oblika urezana na jednoj strani.
The patient should take one 20 mg film-coated tablet (20 mg) per day for 7 days. 
Bolesnik treba uzimati jednu filmom obloženu tabletu od 20 mg dnevno za 7 dana.
• There may be a possibility of reduced serum level of hydrochlorothiazide (HCT) when memantine is coadministered with HCT or any combination with HCT. 
• Pri istodobnoj primjeni memantina i hidroklorotiazida (HCT-a), ili bilo koje od kombinacija s
Pale red, oval film-coated tablet scored in one side. 
Blijedo crvena filmom obložena tableta ovalnog oblika, urezana na jednoj strani.
What Memantine LEK is and what it is used for 
Što je Memantine LEK i za što se koristi Kako djeluje Memantine LEK
In patients with severe renal impairment (creatinine clearance 5 - 29 mL/min) daily dose should be 10 mg per day. 
Kod bolesnika s teškim oštećenjem bubrega (klirens kreatinina 5-29 mL/min) dnevna doza bi trebala biti
Pharmathen International S.A., Industrial Park Sapes, Rodopi Prefecture, Block No 5, Rodopi 69300, Greece Lek Pharmaceuticals d.d., Verovškova 57, 1526 Ljubljana, Slovenia 
Pharmathen S.A , 6, Dervenakion str., 15351 Pallini, Attiki, Grčka Pharmathen International S.A., Industrial Park Sapes, Rodopi Prefecture, Block No 5, Rodopi 69300,
How to store Memantine LEK 
Kako čuvati Memantine LEK
organizacna zlozka Tel: + 421-2/48 200 600 
Slovenská republika Sandoz d.d. organizacna zlozka Tel: + 421-2/48 200 600
10 mg: Film-coating: polyvinyl alcohol, titanium dioxide (E-171), talc, macrogol 3350 and iron oxide yellow (E 
Film ovojnica: poli(vinilni alkohol), titanijev dioksid (E171), talk, makrogol 3350 i žuti željezov oksid (E172).
Estonia Tel: + 372 6652405 
Sandoz d.d. Estonia Tel: + 372 6652405
Each 20 mg tablet contains 20 mg of memantine hydrochloride equivalent to 16.62 mg memantine. 
Jedna 20 mg tableta sadrži 20 mg memantinklorida što odgovara 16,62 mg memantina.
Package leaflet: Information for the user Memantine LEK 10 mg film-coated tablets Memantine LEK 20 mg film-coated tablets memantine hydrochloride 
Uputa o lijeku: Informacije za korisnika Memantin LEK 10 mg filmom obložene tablete Memantin LEK 20 mg filmom obložene tablete memantinklorid
Each 10 mg tablet contains 10 mg of memantine hydrochloride equivalent to 8.31 mg memantine. 
Jedna 10 mg tableta sadrži 10 mg memantinklorida što odgovara 8,31 mg memantina.
A pivotal monotherapy study in a population of patients suffering from moderate to severe Alzheimer's disease (mini mental state examination (MMSE) total scores at baseline of 3 - 14) included a total of 252 outpatients. 
Alzheimerove bolesti (početne vrijednosti kratkog testa određivanja mentalnog statusa (MMSE) bile su 3-14) uključivalo je ukupno 252 ambulantna bolesnika.
PC: 
Tel.:
Memantine-treated patients showed a statistically significantly better effect than placebo-treated patients on the primary endpoints: Alzheimer's disease assessment scale (ADAS-cog) (p=0.003) and CIBIC-plus (p=0.004) at week 24 last observation carried forward (LOCF). 
Bolesnici liječeni memantinom pokazali su statistički značajno bolji učinak nego bolesnici koji su primali placebo u pogledu primarnih ishoda: skala procjene Alzheimerove bolesti (ADAS-cog) (p=0,003) i CIBIC-plus
Memantine LEK 20 mg film-coated tablets are available in PVC/PVDC-Aluminium blister packs of 28, 30, 42, 56, 98 and 100 tablets. 
Memantine Lek 20 mg filmom obložene tablete su dostupne u PVC/PVDC-aluminij blister pakiranju sa 28, 30, 42, 56, 98 i 100 tableta.
EU/1/13/826 /007 28 film-coated tablets EU/1/13/826 /008 30 film-coated tablets EU/1/13/826 /009 42 film-coated tablets EU/1/13/826 /010 56 film-coated tablets EU/1/13/826 /011 98 film-coated tablets EU/1/13/826 /015 100 film-coated tablets 
EU/1/13/826 /007 28 filmom obloženih tableta EU/1/13/826 /008 30 filmom obloženih tableta EU/1/13/826 /009 42 filmom obloženih tableta EU/1/13/826 /010 56 filmom obloženih tableta EU/1/13/826 /011 98 filmom obloženih tableta EU/1/13/826 /015 100 filmom obloženih tableta
QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 20 mg of memantine hydrochloride equivalent to 16.62 mg memantine. 
KVALITATIVNI I KVANTITATIVNI SASTAV Jedna filmom obložena tableta sadrži 20 mg memantinklorida, što odgovara 16,62 mg memantina.
In clinical trials in mild to severe dementia, involving 1,784 patients treated with memantine and 1,595 patients treated with placebo, the overall incidence rate of adverse reactions with memantine did not differ from those with placebo; the adverse reactions were usually mild to moderate in severity. 
1595 ih je dobivalo placebo, sveukupna stopa incidencije nuspojava u skupini liječenoj memantinom nije se razlikovala od stope incidencije nuspojava u skupini koja je primala placebo.
Memantine LEK 10 mg film-coated tablets are available in PVC/PVDC-Aluminium blister packs of 28, 30, 42, 50, 56, 60, 98, 100 and 112 tablets. 
Memantine Lek 10 mg filmom obložene tablete su dostupne u PVC/PVDC-aluminij blister pakiranju sa 28, 30, 42, 50, 56, 60, 98, 100 i 112 tableta.
These factors include drastic changes in diet, e.g. from a carnivore to a vegetarian diet, or a massive ingestion of alkalising gastric buffers. 
prelazak s mesne na vegetarijansku prehranu ili uzimanje izrazito velike količine alkalizirajućih želučanih pufera.
NAME OF THE MEDICINAL PRODUCT Memantine LEK 10 mg film-coated tablets 
NAZIV LIJEKA Memantin LEK 10 mg filmom obložene tablete
Tel: + 386 1 580 3327 
Lek Pharmaceuticals d.d. Tel: + 386 1 580 3327
Aluminium-PVC/PVDC blisters placed into cardboard boxes containing 28, 30, 42, 50, 56, 60, 98, 100 and 112 film-coated tablets. 
Aluminij-PVC/PVDC blisteri, pakirani u kartonske kutije koje sadrže 28, 30, 42, 50, 56, 60, 98, 100 i 112 filmom obloženih tableta.
NAME OF THE MEDICINAL PRODUCT Memantine LEK 20 mg film-coated tablets 
NAZIV LIJEKA Memantin LEK 20 mg filmom obložene tablete
half 10 mg tablet week 2 
1. tjedan pola tablete od 10 mg
Aluminium-PVC/PVDC blisters placed into cardboard boxes containing 28, 30, 42, 56, 98 and 100 filmcoated tablets. 
Aluminij-PVC/PVDC blisteri, pakirani u kartonske kutije koje sadrže 28, 30, 42, 56, 98 i 100 filmom obloženih tableta.
Tel: + +420 225 775 111 
Sandoz s.r.o. Tel: + +420 225 775 111
P.T.Hadjigeorgiou Co Ltd Τηλ: + 357 - 25372425 
Τηλ: + 357 - 25372425
NAME OF THE MEDICINAL PRODUCT Memantine LEK 20 mg film-coated tablets memantine hydrochloride 
Memantine LEK 20 mg filmom obložene tablete memantinklorid
In another monotherapy study in mild to moderate Alzheimer's disease a total of 470 patients (MMSE total scores at baseline of 11-23) were randomised. 
U drugom monoterapijskom ispitivanju blage do umjerene Alzheimerove bolesti randomizirano je ukupno 470
Do not take Memantine LEK 
Ako ste zaboravili uzeti Memantine LEK
On the basis of the clinical studies, the recommended dose for patients over the age of 65 years is 20 mg per day (two 10 mg tablets once a day) as described above. 
Temeljem kliničkih ispitivanja, preporučena doza za bolesnike starije od 65 godina iznosi 20 mg na dan,
Slovenská republika Sandoz d.d. 
Sandoz d.d Representative office
NAME OF THE MEDICINAL PRODUCT Memantine LEK 10 mg film-coated tablets memantine hydrochloride 
Memantin LEK 10 mg filmom obložene tablete memantinklorid
Iron oxide yellow (E 172) Iron oxide red (E 172) 
Ovojnica tablete poli(vinilni alkohol) makrogol 3350 titanijev dioksid (E 171) Talk željezov oksid, žuti (E 172) željezov oksid, crveni (E 172)
STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains 20 mg memantine hydrochloride equivalent to 16.62 mg memantine. 
Jedna filmom obložena tableta sadrži 20 mg memantinklorida, što odgovara 16,62 mg memantina.
STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains 10 mg memantine hydrochloride equivalent to 8.31 mg memantine. 
Jedna filmom obložena tableta sadrži 10 mg memantinklorida, što odgovara 8,31 mg memantina.
Dose 
Raspodjela
Dyspnoea 
Doziranje
Tablet coat 
IME NOSITELJA
Generally one kit is sufficient. 
Općenito dovoljan je jedan komplet.
It can be used in the following situations: 
Može se koristiti u sljedećim situacijama:
• patients who are still growing; 
• bolesnicima koji još uvijek rastu;